• Fully reporting, 10-year-old public company with 10,000+ shareholders
• Direct and channel commercialization of its product lines in North America, leading the decentralized water treatment revolution with the Modular Water Systems™ product line, and well positioned for growth in the commercial and industrial ESG space
• Commercializing its patented, chemical-free Electro Water Separation™ and Advanced Oxidation™ technologies through licensing and partnerships worldwide demonstrating a strong history of environmental stewardship
• Made in USA – Texas-strong: fabrication, manufacturing and distribution of factory assembled, highest quality, containerized and packaged water systems and larger commercial and industrial custom-build, advanced water treatment systems
• Advanced technology projects, supporting the boom in localized water treatment systems
• Active licensee network in China, South Asia, Europe and the Middle East
• A global network of partnerships and joint ventures
• Acquisition strategy empowers companies to help water users treat and recycle their own water

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

1. Water Treatment: achieving high grade purification.
2. Water Conveyance: water transportation and pumping.
3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

OriginClear is a growth story and positioned to take full advantage of a major shift from the city to the corporate user; while the company is already operating successfully with strong profit margins, an increasing customer base, and working on accretive acquisitions that could dramatically increase growth.

In just 10 years, the global water services market has doubled into a trillion-dollar industry. Yet, only 20 percent of all sewage, and 30 percent of all industrial waste, are ever treated. Water leakage results in the loss of 35 percent of all clean water across the planet; cutting that number in half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

We can no longer rely on giant, centralized water utilities to meet the challenge. That’s why more and more business users are doing their own water treatment and recycling. Whether by choice or because they have to, those businesses that invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of sight of the general public, self-reliant businesses are quietly building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which drive about a quarter of all professionally managed assets around the world, specifically include the key factor of how well corporations manage water.

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

• InsuraGuest’s Guest Protection Policy covers hotel and vacation rental guests against accidents and damage loss
• The European hotel market is twice the size of that of the U.S., with a valuation of $218 billion; the U.S. vacation rental sector is estimated at $100 billion
• InsuraGuest’s platform can integrate with 70 hotel and vacation rental property management systems and has the potential to access 40,000 properties worldwide

Service-as-a-software (SaaS) company InsuraGuest Inc. is working to expand the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, according to a recent company press release. InsuraGuest has already signed a letter of intent with a licensed Master General Agent operating in these markets, which will allow the company to distribute its products and proprietary platform to the hotel and vacation rental markets in these regions.

The move is likely to bring multiple benefits and opportunity for increased revenue and future growth, as this is a very lucrative market almost twice larger than the U.S. market. According to InsuraGuest CEO Douglas Anderson, there were 2.8 billion hotel nights stayed in Europe, compared to approximately 1.1 billion in the U.S. in 2018.

In the same period, there were 2.6 billion hotel nights stayed in Asia – a market InsuraGuest is also planning to enter in the near future. Currently, the U.S. hotel industry has reached $218 billion in annual revenue, with roughly $100 billion spent on vacation rentals last year (http://ibn.fm/Mu7CF). With distribution in the U.S. and Europe, InsuraGuest will reach a combined demographic of approximately 3.9 billion hotel stays and will double its vacation rental opportunities.

The company’s completed property management system integration currently covers 85 percent of the hotel market. Its InsurTech proprietary platform can integrate with 70 different hotel property management systems, obtaining access to approximately 40,000 properties. In addition, InsuraGuest™ is being integrated with vacation rental property management systems like Hostfully Inc. out of San Francisco and their system Orbirental, which currently has approximately 2,500 properties onboarded.

The platform delivers a specialized guest protection policy to vacation or hotel rental. Created specifically for InsuraGuest, this policy is the first line of defense against accidents and losses both for the guest and the hotel or vacation rental property. Properties can buy the InsuraGuest Guest Protection Policy, which is extended to each individual guest at the time of check-in until check-out. The policy covers loss and accident damages.

InsuraGuest created this insurance product and markets it to hotels and other vacation properties in an attempt to fill an existing gap in travelers’ insurance. Conventional insurance fails to adequately cover the full scope of risks that travelers and hotel or property owners face. There is a lot that can happen inside hotels or other travel properties. Many travelers labor under the misconception that losses or accidents happening at vacation properties are automatically covered by the property owner’s insurance. In cases where an incidence of damage or an accident cannot be attributed to the property directly, the guest may have no claim to coverage at all. InsuraGuest’s InsurTech platform aims to change this.

The company covers up to $5,000 for death or dismemberment, up to $25,000 for medical care following an accident, up to $2,500 for lost or stolen goods, and $1,000 for damage to a occupied room accidentally incurred by the guest.

InsuraGuest is currently focused mostly on the U.S. market, where it operates coast-to-coast. The company expects to be licensed to sell insurance under its own agency nationwide in the very near future. After the move to Europe and the U.K., InsuraGuest is planning to launch its proprietary platform and insurance products in Asia by mid-2020.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

• The lucrative U.S. CBD market is estimated to reach $5 billion this year, marking an impressive 706 percent increase from 2018
• The growing trend is expected to continue, with industry forecasts putting CBD’s CAGR at 107 percent to reach $23.7 billion by 2023
• Wildflower Brands is well positioned to take advantage of this trend and expand its market presence domestically and internationally
• The company’s branded premium products are currently available at 600 locations

The cannabis industry is historically a newcomer to global markets, yet legal sales worldwide reached $11 billion in 2018 from only $3.4 billion 2014 (http://ibn.fm/a8o2Y). The industry’s outlook continues to improve and exponential growth is anticipated, with a projected increase every year, to potentially reach $75 billion by 2030 (http://ibn.fm/PLwRo).

One segment of the industry, however, is set to outperform all others – CBD (cannabidiol). Investors are becoming increasingly aware of CBD’s potential and expected growth. This cannabinoid can be extracted from both the cannabis and the hemp plant, but since hemp plants are considerably cheaper to grow, hemp is typically the preferred crop choice for extraction, which can explain CBD’s star performance.

Industry watchdogs are in full agreement on the CBD market growth trend. Market research company Brightfield Group projected a 706 percent year-on-year increase in U.S. CBD product sales in 2019, to reach $5 billion (http://ibn.fm/Ln9qH). Additionally, the report indicates that CBD sales will reach $23.7 billion by 2023, growing at a compound annual growth rate of 107 percent. For comparison, about $620 million worth of CBD products were sold in the U.S. in 2018.

Companies such as Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) are uniquely positioned to take advantage of the CBD popularity boom but focusing on developing and designing premium branded products for the increasingly discerning consumer. Operating out of Washington State, the company is already selling its products throughout the U.S., has recently entered the Canadian market and aims to further expand its network to other international markets in the future.

As a result of various retail collaborations and strategic partnerships, Wildflower Brands’ CBD products are now available at 600 locations across America, including in over 260 Dillard’s department stores (http://ibn.fm/KyxQW). The initial purchase ordered enabled company products to reach several new states, according to Wildflower Brands CEO William McLean.

Wildflower products are also available at 100 Earthbound Trading locations nationwide, 20 premium health and wellness stores throughout Manhattan, as well as wellness guru Joel Warren’s Saks Fifth Avenue salon (http://ibn.fm/KtIUU).

The company recently completed the strategic acquisition of Canadian-based City Cannabis Corp, which gives it access to four retail stores in Vancouver, British Columbia. Two of these stores were opened in August 2019 (http://ibn.fm/DiFNl).

Wildflower continues to expand into large retail chains, launch new products, and execute its lucrative marketing strategy for e-commerce. A 10,000-square-foot manufacturing facility will be completed in November to boost production, as part of the company’s domestic expansion plans. In terms of online sales, the company receives an average of 900 orders per month and achieved a 3.44 percent conversion rate in October 2019. It boasts a 39 percent returning customer rate and a 300 percent revenue growth rate. The online store, wildflowerUS.com, is in the top two percent of all Shopify stores that launched in 2017.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• SinglePoint returns from NACS show with 75 leads and potential for 3,000 accounts
• The company closed a record $50,000 in hemp-cigarette sales onsite
• SING’s Direct Solar subsidiary continues to post record sales figures

SinglePoint Inc. (OTCQB: SING), a diversified holding company with operations in multiple industries and verticals including legal cannabis, just returned from a stellar showing at the October National Association of Convenience Stores (NACS) Show, held in Las Vegas. Singlepoint founder and CEO Greg Lambrecht shared the positive news this week during an interview on MoneyTV with Donald Baillargeon (http://ibn.fm/aYbxy).

“We just really did well there at the NACS show,” Lambrecht stated in the interview, noting that SING was one of the only booths to feature hemp cigarettes. “We did a pretty massive direct-marketing campaign to get people to the booth. We were busy the whole three days, and we had six people manning the booth. We probably had about four to five hundred people come through our booth. We just put together 75 leads in SalesForce, which equals about 3,000 accounts.”

Lambrecht noted that many of the visitors to the booth were buyers for chain stores, some numbering in the hundreds. The company is now following up on each lead.

In addition to following up with interested buyers, SING is also busy filling orders that were actually placed during the show – the company closed on $50,000 worth of sales onsite. “It’s incredible,” said Lambrecht, who noted that taking onsite orders wasn’t even an option in his “previous life” doing trade shows. “And now we’re able to swipe credit cards right on our phones and take orders at the show.”

Singlepoint isn’t worried about meeting demand for its popular Pure American Hemp Cigarettes. The company ordered two pallets of product delivered to its California facility: the first will be used to fill the onsite orders, and the second will provide ready inventory for anticipated orders from NACS leads.

“We’re expecting additional sales,” Lambrecht continued. “We’re well on our way. We could be one of the leaders in the hemp cigarette business.” The Singlepoint exec noted that the company plans to attend future shows as well, including the MJBizCon conference slated for December. “We picked the right product, and we really have the right team,” he says. “We expect huge things from the hemp business.”

In addition to SING’s booming hemp cigarette business, Lambrecht noted that there was “nothing but great news on Direct Solar as well.” Singlepoint’s Direct Solar subsidiary (http://ibn.fm/42Udy) is a solar energy brokerage focused on finding and installing “the best available solar-energy system for any building residential or commercial for no money down, no cost for an estimate.” The company, which SING acquired earlier this year, has surpassed expectations by signing contracts to deploy more than $1.7 million in solar installs in a one-month period, then adding up to a two-month total of nearly $3.5 million in contracts.

“[Direct Solar is] doing as well as they ever have and even better,” Lambrecht added. “Their sales are getting better every month as they grow…We’re pretty excited to show the audience and all of our shareholders our revenues for third quarter. Singlepoint is continuing to increase their revenues and their profits and their balance statement. This is really going to be a great year for us in 2020. I expect again to do somewhere between $15 and $20 million in revenue, and I expect the stock to follow.”

Singlepoint Inc. is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• SPRWF subsidiary Blissco recently received Health Canada licensing approval to sell cannabis oils
• Blissco expected to produce more than seven million tincture bottles annually
• Supreme Cannabis says that the subsidiary will make a significant impact on its FY2020 revenues

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies including subsidiary Blissco Cannabis Corp., announced that Blissco has received licensing approval from Health Canada for the sale of cannabis oils from its Langley, British Columbia, facility (http://ibn.fm/KvUBF). The highly anticipated licensing means that Blissco now has government approval to sell full spectrum cannabidiol (CBD) oil products.

Supreme Cannabis closed its acquisition of Blissco—a wellness cannabis brand and multiprocessor and distributor based in British Columbia—in the first quarter of FY2020 (http://ibn.fm/OYwtS). It has been making strategic moves toward this licensing milestone. By improving the efficiency and focus of Blissco’s business operations, including initiating construction on a large-scale ethanol-based extraction lab, Supreme Cannabis has been working to expand Blissco’s extraction capabilities. The company predicts that its facility will be able to produce over seven million tincture bottles annually, making the Blissco brand a significant driver to SPRWF’s projected revenue in FY2020.

The subsidiary’s ability to produce and sell high-quality CBD oil products means Blissco sales will be a significant factor in SPRWF’s projected FY2020 revenue. The company expects to launch its first CBD oil product in the Canadian market by the second quarter of FY2020 with plans to follow up that initial product offering with a suite of complementary cannabis extract products in subsequent quarters.

“With the receipt of the license and expanded extraction capacity, Blissco will be positioned to address the growing unmet demand for high-quality, CBD oil products across Canada,” said Supreme Cannabis CEO Navdeep Dhaliwal. “Blissco’s legacy of premium, whole-flower products established a brand that represents quality and authenticity to wellness consumers. For over a year, Blissco’s team developed advanced oil-processing and formulation capabilities based on the same ethos. Consumers will soon be able to experience high-quality CBD oil products from a premium wellness brand they have come to trust.”

In addition, SPRWF has appointed Todd McAdam as general manager of the Blissco facility; his responsibilities will include managing and supporting the production, sale, and distribution of Blissco’s high-quality products. A highly experienced operations professional, McAdam has spent more than 30 years working in the food and beverage industries. Most recently, he served as general manager at Labatt Breweries of Canada’s Turning Point Brewery in British Columbia.

In addition to Blissco, the Supreme Cannabis portfolio includes 7ACRES, an award-winning brand; Cambium Plant Sciences, a cultivation IP and plant-genetics company; Medigrow Lesotho, a Southern Africa cannabis-oil producer; Supreme Heights, the investment platform focused on CBD; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• The new strategic advisor, Dr. William Li, is a globally recognized medical professional
• One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances
• Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management
• Its Electroceutical® SofPulse® is clinically proven to provide post-operative pain relief and speed up recovery

On September 30, 2019, Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of innovative medical devices, announced the appointment of Dr. William Li as a strategic advisor to the CEO. The role of Li would be to strategically explore growth opportunities within the Endonovo target markets, the company said in a press release (http://ibn.fm/mCqAT).

“Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,” Endonovo Therapeutics CEO Alan Collier said in a news release. Just like the Endonovo team, Li sees the long-term potential of medical innovations and their ability to change the industry, Collier added.

According to Li, “Endonovo has a strong technology platform with game changing potential. The company’s clinical-stage wearable Electroceutical® therapeutic device, SofPulse®, can address pain, wound healing, post-surgical pain, edema, central nervous system disorders and various other conditions.”

“Endonovo is poised to go to the next level across a range of industry verticals. I look forward to working with Alan and the Endonovo team to evaluate the Company’s operational and strategic opportunities,” Li added.

One of Li’s focal areas of experience is the identification of unmet needs in the healthcare space, especially if cost-effective innovative technology can offer a solution.

Li is the CEO and co-founder of the Angiogenesis Foundation. He gained experience under the guidance of Dr. Judah Folkman – one of the angiogenesis pioneers. Li has been actively involved in angiogenesis and clinical research for more than 30 years. Li graduated from Harvard and completed his medical residency training at Massachusetts General Hospital in Boston. He serves as a consultant to various leading global public and private companies.

Endonovo Therapeutics is currently developing solutions to meet major therapeutic needs. The company’s innovative SofPulse® device delivers clinically proven post-operative pain relief for patients, reducing the need for opioid use.

SofPulse® delivers targeted pulsed electromagnetic field therapy to significantly speed up the recovery process after surgery. It improves the patient’s natural recovery experience and can be a better alternative to opioid-based pain medications, thus helping tackle the current opioid crisis.

According to U.S. federal statistics, opioids kill more people per year than automobile accidents. In 2018 alone, 68,000 Americans died of a drug overdose stemming from opioid abuse (http://ibn.fm/BsSiX). This is a significant increase from 18,515 opioid-related deaths in 2007.

The general population and the medical community are both pushing for a change in which chronic and post-operative pain are handled. Unfortunately, few alternatives to opioids exist. SofPulse® is one of the innovative solutions that could diminish the use of medications and give patients satisfactory pain management.

Endonovo’s therapy is cleared by the U.S. Food and Drug Administration for the palliative treatment of post-surgical pain and edema. It is also CE-marked in the European Economic Area for the promotion of wound healing and the palliative treatment of post-surgical pain and edema.

For more information, visit the company’s website at www.Endonovo.com

NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV

• In a YouTube interview, Supreme Cannabis CEO Navdeep Dhaliwal stated that investors should focus on the company’s strong balance sheet
• Supreme Cannabis reported $41.8 million in sales for FY2019, as compared to $8.9 million in FY2018, marking a 370 percent year-over-year jump; the company also reported its first positive adjusted EBITDA
• Dhaliwal further noted that the performance of subsidiary 7ACRES is key to the company’s growth

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of cannabis companies, projects that its fiscal 2020 net revenues will increase to an estimated $150 million to $180 million, with a positive adjusted EBITDA. In FY2019, Supreme Cannabis reported net revenues of $41.8 million, including its first positive adjusted EBITDA quarter of $3.2 million (http://ibn.fm/PkcSB). FY2019 net revenue total itself was a 370 percent improvement compared to the company’s $8.9 million in cannabis sales posted for FY2018.

Supreme Cannabis CEO and director Navdeep Dhaliwal said during a YouTube interview with Evan Veryard, president of Capital 10X, that he believes the cannabis industry is entering a period where companies with strong business fundamentals will dominate.

“It’s an inflection point,” Dhaliwal noted in the interview in reference to Supreme Cannabis’ projections for FY2020 net revenues (http://ibn.fm/QiIVS). “You’re starting to see a real separation between strong businesses and strong core operations that are going to be strong, dominant long-term with competitive advantage. We’re excited about this period in the market because business fundamentals are going to take over and a lot of the noise is going to go away.”

In the interview, Dhaliwal noted that investors should look at the strong balance sheet of Supreme Cannabis. “We have a very healthy cash balance, and we’re fully funded for all our planned business objectives,” he observed, adding that Supreme Cannabis is in a good position to receive non-diluted debt financing from tier-one lenders and to “fulfill all of our obligations, specifically to debentures which are due in 2020 and 2021… It is really about balance: building strong businesses, investing prudently in growth and taking a data-driven approach. Test and validate and then a scale approach. That’s our strategy.”

As a diversified consumer-driven business, Supreme Cannabis is also focused on high-margin, premium quality products, Dhaliwal observed. The company wants to please its highly discerning consumers with the highest quality products. One example of that focus, he pointed out, is the company’s 7ACRES subsidiary, which recently launched Jack Haze, its first proprietary strain.

Jack Haze is 7ACRES’ first sativa-dominant strain with rare sensory characteristics (http://ibn.fm/ejmYM). Plans call for more unique strains to be introduced in the future as the company differentiates 7ACRES’ high-end flower offering and earns premium pricing across Canada.

The Supreme Cannabis portfolio includes 7ACRES, an award-winning brand; Cambium Plant Sciences, a cultivation IP and plant-genetics company; Medigrow Lesotho, a Southern Africa cannabis-oil producer; Supreme Heights, the investment platform focused on CBD; Blissco Cannabis Corp, a wellness cannabis brand and a multiprocessor and distributor based in British Columbia; and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• IONIC Brands is a manufacturer of premium cannabis products with a diverse portfolio
• The company recently acquired Zoots Premium Cannabis and its variety of drops, gummies, energy shots, and hard candies, sold in Illinois, Washington, Colorado, and Massachusetts
• IONIC is also preparing to build on its patents for brewing cannabis-infused coffee, tea, and cocoa
• The edibles market was valued at approximately $2.4 billion in 2018 with expected revenues of about $11.6 billion by 2025

Recreational adult-use cannabis continues to make headlines amid growing legalization throughout North America, providing opportunities for national cannabis holdings company IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) and its portfolio of premium luxury products.

In the United States, Pennsylvania is contemplating legislation that could make it the eleventh state in the nation to legalize recreational-use marijuana in the birthplace of America’s revolution (http://ibn.fm/adRxP). Canada’s long-anticipated legalization of food-and-beverage cannabis products occurred October 17, opening the door for the first legal edibles and infused drinks to reach the market in December (http://ibn.fm/oaLTR). In Mexico, the Senate is expected to pass a bill during the coming week that could decriminalize marijuana if it is subsequently approved by the lower House and dodges an opposition referendum (http://ibn.fm/NtXgC).

Pro-cannabis fervor has swept much of the world during recent years following decades of prohibition that enhanced a black market eager to supply unabashed marijuana users. The sea change in societal opinion on the leafy plant’s products has fortified commercial enterprises operating above board in compliance with governmental regulations, including IONIC.

IONIC added Natural Extractions Inc., doing business as Zoots Premium Cannabis Infused Edibles, to its family of recreational cannabis products in July, welcoming an array of drops, gummies, energy shots and hard candies manufactured to offer consistent and reliable dosing that are sold at licensed marijuana retailers in Illinois, Washington, Colorado and Massachusetts (http://ibn.fm/yVls5).

The West Coast-based companies acknowledged a February Zion Market Research report that valued the global cannabis edibles market at approximately $2.4 billion in 2018 with expected revenues of about $11.6 billion by 2025 at a CAGR of around 25.4 percent between 2019 and 2025 (http://ibn.fm/1Xhx3).

IONIC also entered the infused beverage market with secured patents in the single-serve coffee and beverage pod market during the spring. The announced patents are among the first cannabis patents in the country’s history, slated for brewing cannabis-infused coffee, tea and cocoa from CannaCafe (http://ibn.fm/kyF7z) – a potential multi-billion-dollar market in its own right.

The company’s edibles and beverage offering provide alternatives to consumers put off by recent health concerns surrounding vape pen use for recreational cannabis use. The mysterious vaping-related disease that’s killed at least 26 people from 21 states since April has been branded EVALI, short for e-cigarette or vaping product use-associated lung injury, by the US Centers for Disease Control and Prevention (CDC), the federal health agency that acknowledged it has not been able to determine the precise cause(s) of EVALI and issued a recommendation against using any type of e-cigarette or vaping product until a proper conclusion can be reached (http://ibn.fm/H4fVH).

Because IONIC’s cornerstone products are vapes and related materials, the company issued a statement recently acknowledging a preponderance of evidence that appears to indicate the EVALI illnesses have resulted from illegal, black market vape use (http://ibn.fm/ybOCD). IONIC’s statement notes the company’s commitment to using only the highest quality materials, exclusively sourced from licensed producers of integrity that use state of the art equipment and ensure strict operating practices.

The company also notes it has never and will never use any additives that contain Vitamin E acetate or additives that are based on petrochemicals, two substances suspected of contributing to the EVALI outbreak.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://ibn.fm/IONKF

• ETST’s super-critical extraction process from industrial hemp plants keeps plants’ natural occurring properties intact
• ETST plans expansion of CBD products over the next five years
• Company’s products offer “full spectrum” cannabinoid profile, whereas most cannabis companies focus on the benefits of CBD alone

Earth Science Tech Inc. (OTCQB: ETST), a diverse biotech company focused on the nutraceutical and pharmaceutical fields, offers a unique product line of full-spectrum cannabinoid oils that have a distinct advantage in the competitive nutraceutical market. ETST’s high-pressure, low-heat CO2 extraction process delivers seven distinct cannabinoids, maximizing all the natural therapeutic benefits of the industrial hemp plant (http://ibn.fm/DJdu2) (http://ibn.fm/rmGbz).

The unique process of extraction from industrial hemp plants grown by generational farmers in Oregon, Colorado, and Kentucky results in a full-spectrum cannabinoid oil that is natural and free from synthetic cannabinoids found in some competitors’ products. In addition, the CO2 extraction process results in more of the natural-occurring properties of the plant being left intact. ETST believes Its formulations and proprietary products are unique and distinguish the company from the competition. In its September 2019 SEC filing, Earth Science Tech said it plans to expand manufacturing and marketing of its CBD products over the next five years.

The ETST SEC filing and analysis report said the company intends to create CBD-rich hemp oil and other CBD-containing products unique to the current market in the nutraceuticals industry. Earth Science Tech believes its proprietary formulations set it apart from competing products for promoting health. The company intends to offer its line of health and nutrition products to consumers online and through brick-and-mortar clinics, pharmacies, and retail stores. ETST’s unique products include high-quality supplement brands and proprietary, CBD-rich hemp oil.

“We believe our high-grade, CBD-rich hemp oil contains the high-quality, natural CBD because it’s formulated using a wide array of cutting-edge technologies, including super-critical extraction process (CO2), isolation and micron filtration,” the SEC filing noted. “Super-critical extraction is a gentle approach and the key method in the extraction of our CBD. The method exploits the fact that CO2 at low temperature and under high pressure becomes liquid and thereby draws the cannabinoids and terpenes from the plant material.” The process results in more detectable amounts of important cannabinoids than found in some competitor products, ETST said. The company also noted that its hemp oil is lab tested multiple times throughout the manufacturing process, from seed to shelf. Tests include cannabinoid panel content, terpenoids, micros and residual solvents.

While many cannabis companies are touting the benefits of CBD only in their products, ETST’s products boast a cannabinoid profile with higher content and detectable amounts of other important cannabinoids. For consumers desirous of the full range of benefits cannabinoids have to offer, ETST’s “full spectrum” products deliver on that promise.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Endonovo Therapeutics is developing a bioceutical device that provides an alternative to the prescription pain pills blamed for hundreds of thousands of deaths in recent years as part of a multinational opioid crisis
• Endonovo’s proprietary SofPulse® flagship device provides an electrical micro-current to the afflicted part of the body, particularly post-surgery, to minimize a patient’s need for pain relief medication
• A foot and ankle specialist in Ohio recently used the device following her own tendon surgery and provided a personal testimonial with a professional perspective of the device’s effectiveness in minimizing her pain
• The SofPulse® device is being evaluated professionally under a plan to be in up to 600 U.S. hospitals by the end of next year

When a foot and ankle medical specialist underwent surgery recently for her own tendon reconstruction need, she presented bioelectronic device maker Endonovo Therapeutics Inc. (OTCQB: ENDV) with a first-person professional perspective of Endonovo’s non-opioid pain relief solution that showcases Endonovo’s revolutionary potential for alleviating an international drug-dependency crisis.

In a home-made video, Dr. Jane Graenber, DPM, of the Foot and Ankle Wellness Center in Delaware, Ohio, attests that Endonovo’s SofPulse® electroceutical device has helped her to remain generally pain-free a day after the tendon surgery, such that she says she has only used three doses of Tylenol for relief (no prescription pain pills) during the interim since her procedure (http://ibn.fm/H2n5X).

“This device is putting out a micro-current to my surgical area every two hours… And it’s taken care of the pain, and I’m sitting here very comfortably,” Graenber states in the video. “At our practice we may be starting to include this post-operatively as an option to reduce pain. This was a pretty big surgery and I’m really very comfortable. So I’m giving credit to a good surgeon but also a new device that may revolutionize pain (treatment) after surgery.”

Endonovo announced its initial strategy to begin a national rollout of the SofPulse® on June 13 with plans to be in the evaluation stage at 600 U.S. hospitals through the end of next year (http://ibn.fm/P0w4a). Graenber identifies the video’s date as August 3, countering a time stamp at the bottom of the video that says it was recorded in January 2015.

The proliferation of opioids for pain relief following medical procedures during the past two decades has generated worldwide concerns about the prescription pills’ apparent role in creating patients’ ensuing drug addictions – addictions that have been cited in the deaths of hundreds of thousands of people. The Centers for Disease Control and Prevention states that as of 2017, its statistics showed an average of 130 Americans were dying every day from an opioid overdose (http://ibn.fm/4e49T).

The concerns about opioid abuse have sparked a multi-national sea change in attitudes regarding marijuana use as a medical therapy, although the cannabis plant’s products remain controversial with many governmental regulators. Endonovo’s SofPulse® provides a non-drug alternative to treating pain relief, entirely bypassing concerns about potential substance abuse and harmful side effects.

Furthermore, a recent scientific study of patient outcomes is countering the popularly held idea that marijuana reform is reducing the number of opioid-related deaths. The study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) in June found that states where cannabis legislation has eased access to medical marijuana as an alternative to opioids have actually seen an increase in opioid-related deaths in recent years, rather than a decrease (http://ibn.fm/0BsyR).

“Cannabinoids have demonstrated therapeutic benefits, but reducing population-level opioid overdose mortality does not appear to be among them,” the study states.

Endonovo’s therapy platform has received clearance for the palliative treatment of post-operative pain and swelling from the U.S. Federal Drug Administration, insurance coverage for chronic wound treatment from the national Centers for Medicare and Medicaid Services, and a CE-mark certification that denotes conformity with European Economic Area health and environmental standards related to wound, pain and edema treatment.

For more information, visit the company’s website at www.Endonovo.com

NOTE TO INVESTORS: The latest news and updates relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV